Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 49Leukemia, Lymphocytic, Chronic, B-Cell 19Lymphoma, Non-Hodgkin 12Lymphoma, Large B-Cell, Diffuse 12Lymphoma 12Recurrence 10Lymphoma, Mantle-Cell 9Lymphoma, Follicular 7Leukemia, Myeloid, Acute 7Waldenstrom Macroglobulinemia 6Neoplasms, Plasma Cell 6Myelodysplastic Syndromes 6Lymphoma, B-Cell, Marginal Zone 6Leukemia 6Lymphoma, T-Cell, Peripheral 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Burkitt Lymphoma 4Sezary Syndrome 3Prostatic Neoplasms 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Ovarian Neoplasms 3Mycosis Fungoides 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, T-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, B-Cell 3Immunoblastic Lymphadenopathy 3Hodgkin Disease 3Carcinoma, Non-Small-Cell Lung 3

Interventions

Dexamethasone 2melflufen 1dexamethasone acetate 1dexamethasone 21-phosphate 1daratumumab 1dabrafenib 1belinostat 1auricularum 1Thalidomide 1Pharmacogenomic Testing 1Lenalidomide 1L-melphalanyl-p-L-fluorophenylalanine ethyl ester 1Cyclophosphamide 1Calcium Dobesilate 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Renal Insufficiency × Lenalidomide × Clear all
NCT04352205 2024-07-01

Daratumumab-Based Therapy for the Treatment of Newly Diagnosed Multiple Myeloma With Kidney Failure

Emory University

Phase 2 Terminated
17 enrolled
Plasma cell

Multiple Myeloma, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡